Showing results (651-660 of 5,681) with videos related to

Sort By:
Pageof 569
The Oncologist|December 14, 2018
Low Prevalence of the Four Common Colombian Founder Mutations in BRCA1 and BRCA2 in Early-Onset and Familial Afro-Colombian Patients with Breast CancerElizabeth Vargas, Diana Maria Torres Lopez, Robert de Deugd, et al.
The Oncologist|December 14, 2018
Biomarkers for Programmed Death-1 Inhibition in Prostate CancerCharlotte Manogue, Patrick Cotogno, Elisa Ledet, et al.
The Oncologist|January 4, 2019
An Open-Label Phase II Trial of Bevacizumab plus Docetaxel and Gemcitabine in Advanced, Previously Untreated Nonsquamous Non-Small Cell Lung CancerPradnya Dinkar Patil, Marc Shapiro, Nooshin Hashemi Sadraei, et al.
The Oncologist|December 19, 2018
Apatinib for Advanced Osteosarcoma after Failure of Standard Multimodal Therapy: An Open Label Phase II Clinical TrialLu Xie, Jie Xu, Xin Sun, et al.
The Oncologist|December 22, 2018
Modulation of Premetastatic Niche by the Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor Pazopanib in Localized High-Risk Prostate Cancer Followed by Radical Prostatectomy: A Phase II Randomized TrialBenjamin L Maughan, Sumanta K Pal, David Gill, et al.
The Oncologist|January 23, 2020
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating LymphocytesFotios Loupakis, Ilaria Depetris, Paola Biason, et al.
The Oncologist|January 21, 2020
Clinicopathological Features Predict Outcomes in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Real-World StudyLin Cheng, Hao Fu, Yuchen Jin, et al.
The Oncologist|April 4, 2020
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative GroupHumaid O Al-Shamsi, Waleed Alhazzani, Ahmad Alhuraiji, et al.
The Oncologist|April 7, 2020
A Prospective Study of Apatinib in Patients with Extensive-Stage Small Cell Lung Cancer After Failure of Two or More Lines of ChemotherapyYutao Liu, Xingsheng Hu, Jun Jiang, et al.
The Oncologist|August 30, 2020
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive-Stage Small Cell Lung CancerBarbara Melosky, Parneet K Cheema, Anthony Brade, et al.
Pageof 569